GLP1R and Anxiety: Specifically, abstinence symptoms during withdrawal such as anxiety is prevented by liraglutide (the GLP-1R agonist) or sitagliptin (a DPP-IV inhibitor that enhances endogenous GLP-1) (53, 54).